These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 36500494)

  • 1. The Multiple Sclerosis Modulatory Potential of Natural Multi-Targeting Antioxidants.
    Theodosis-Nobelos P; Rekka EA
    Molecules; 2022 Dec; 27(23):. PubMed ID: 36500494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efforts Towards Repurposing of Antioxidant Drugs and Active Compounds for Multiple Sclerosis Control.
    Theodosis-Nobelos P; Rekka EA
    Neurochem Res; 2023 Mar; 48(3):725-744. PubMed ID: 36385213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Review of Various Antioxidant Compounds and their Potential Utility as Complementary Therapy in Multiple Sclerosis.
    Miller ED; Dziedzic A; Saluk-Bijak J; Bijak M
    Nutrients; 2019 Jul; 11(7):. PubMed ID: 31284389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondria-targeted Antioxidants as a Prospective Therapeutic Strategy for Multiple Sclerosis.
    Fetisova E; Chernyak B; Korshunova G; Muntyan M; Skulachev V
    Curr Med Chem; 2017; 24(19):2086-2114. PubMed ID: 28302008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy.
    Gilgun-Sherki Y; Melamed E; Offen D
    J Neurol; 2004 Mar; 251(3):261-8. PubMed ID: 15015004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation.
    Wang JY; Wen LL; Huang YN; Chen YT; Ku MC
    Curr Pharm Des; 2006; 12(27):3521-33. PubMed ID: 17017945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidants in multiple sclerosis: do they have a role in therapy?
    Carlson NG; Rose JW
    CNS Drugs; 2006; 20(6):433-41. PubMed ID: 16734496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress induced by lipid peroxidation is related with inflammation of demyelination and neurodegeneration in multiple sclerosis.
    Wang P; Xie K; Wang C; Bi J
    Eur Neurol; 2014; 72(3-4):249-54. PubMed ID: 25277682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress involvement in the molecular pathogenesis and progression of multiple sclerosis: a literature review.
    Sanabria-Castro A; Alape-Girón A; Flores-Díaz M; Echeverri-McCandless A; Parajeles-Vindas A
    Rev Neurosci; 2024 Apr; 35(3):355-371. PubMed ID: 38163257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant.
    Binyamin O; Larush L; Frid K; Keller G; Friedman-Levi Y; Ovadia H; Abramsky O; Magdassi S; Gabizon R
    Int J Nanomedicine; 2015; 10():7165-74. PubMed ID: 26648720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative Status in Multiple Sclerosis and Off-Targets of Antioxidants: The Case of Edaravone.
    Agresti C; Mechelli R; Olla S; Veroni C; Eleuteri C; Ristori G; Salvetti M
    Curr Med Chem; 2020; 27(13):2095-2105. PubMed ID: 30678613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant and Anti-inflammatory Diagnostic Biomarkers in Multiple Sclerosis: A Machine Learning Study.
    Mezzaroba L; Simão ANC; Oliveira SR; Flauzino T; Alfieri DF; de Carvalho Jennings Pereira WL; Kallaur AP; Lozovoy MAB; Kaimen-Maciel DR; Maes M; Reiche EMV
    Mol Neurobiol; 2020 May; 57(5):2167-2178. PubMed ID: 31970657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in antioxidative therapy of multiple sclerosis.
    Miller E; Wachowicz B; Majsterek I
    Curr Med Chem; 2013; 20(37):4720-30. PubMed ID: 23834174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurodegeneration by oxidative stress: a review on prospective use of small molecules for neuroprotection.
    Singh E; Devasahayam G
    Mol Biol Rep; 2020 Apr; 47(4):3133-3140. PubMed ID: 32162127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Insights into the Role of Oxidative Stress Mechanisms in the Pathophysiology and Treatment of Multiple Sclerosis.
    Adamczyk B; Adamczyk-Sowa M
    Oxid Med Cell Longev; 2016; 2016():1973834. PubMed ID: 27829982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Effect of the Mitochondria-Targeted Antioxidant SkQ1 on the Culture Model of Multiple Sclerosis.
    Fetisova EK; Muntyan MS; Lyamzaev KG; Chernyak BV
    Oxid Med Cell Longev; 2019; 2019():2082561. PubMed ID: 31354902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oxidative stress and natural antioxidant mechanisms: the role in neurodegeneration. From molecular mechanisms to therapeutic strategies].
    Karpińska A; Gromadzka G
    Postepy Hig Med Dosw (Online); 2013 Jan; 67():43-53. PubMed ID: 23475482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing of Secukinumab as Neuroprotective in Cuprizone-Induced Multiple Sclerosis Experimental Model via Inhibition of Oxidative, Inflammatory, and Neurodegenerative Signaling.
    Abdel-Maged AE; Gad AM; Rashed LA; Azab SS; Mohamed EA; Awad AS
    Mol Neurobiol; 2020 Aug; 57(8):3291-3306. PubMed ID: 32514862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of Parameters of Oxidative Stress in vitro Models of Neurodegenerative Diseases-A Review.
    Feitosa CM; da Silva Oliveira GL; do Nascimento Cavalcante A; Morais Chaves SK; Rai M
    Curr Clin Pharmacol; 2018; 13(2):100-109. PubMed ID: 29493463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.